Recombinant Human HAPLN1 Mitigates Pulmonary Emphysema by Increasing TGF-β Receptor I and Sirtuins Levels in Human Alveolar Epithelial Cells

Chronic obstructive pulmonary disease (COPD) will be the third leading cause of death worldwide by 2030. One of its components, emphysema, has been defined as a lung disease that irreversibly damages the lungs’ alveoli. Treatment is currently unavailable for emphysema symptoms and complete cure of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Piao, Yongwei, Yun, So Yoon, Fu, Zhicheng, Jang, Ji Min, Back, Moon Jung, Kim, Ha Hyung, Kim, Dae Kyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495690/
https://www.ncbi.nlm.nih.gov/pubmed/37587649
http://dx.doi.org/10.14348/molcells.2023.0097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495690/
https://www.ncbi.nlm.nih.gov/pubmed/37587649
http://dx.doi.org/10.14348/molcells.2023.0097

Ejemplares similares